PharmaCyte Biotech Inc (NASDAQ:PMCB)
| 2.09 Delayed Data As of Sep 27 |  -0.08 / -3.69%Today’s Change | 2.08 Today|||52-Week Range 3.23 | -28.67% Year-to-Date |
Latest PMCB News | Press Releases
No recent news for PharmaCyte Biotech Inc.
Today’s Trading
| Previous close | 2.17 |
| Today’s open | 2.17 |
| Day’s range | 2.09 - 2.21 |
| Volume | 26,884 |
| Average volume (3 months) | 30,155 |
| Market cap | $20.4M |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | +18.89% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Financials
| Last reporting date | August 22, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Las Vegas, Nevada |
Forecasts
